Thyroid Function Targets in Pregnancy

Monitoring and Treatment

The American Family Physician recommends evaluating thyroid function every trimester to adjust the levothyroxine dose as necessary, with the goal of maintaining free T4 in the high-normal range using the lowest possible medication dose 1, 2
Untreated hypothyroidism during pregnancy can cause adverse effects in both the mother and fetus, including preeclampsia and low birth weight 2
The American Family Physician also notes that inadequate treatment of hypothyroidism is associated with low birth weight 2
Iodine deficiency during pregnancy can increase the risk of congenital cretinism (mental retardation and other neuropsychological defects) 2

Maternal hypothyroxinemia (low T4 with normal TSH) has been associated with alterations in fetal neuropsychological development and increased risk of fetal loss, and treatment with levothyroxine is recommended to restore T4 levels to the normal range 3

Subclinical hypothyroidism (elevated TSH with normal T4) during pregnancy is associated with increased risks of adverse maternal and fetal outcomes, including preeclampsia, low birth weight, and impaired neuropsychological development in the offspring, as reported by the American Family Physician 4

Measure thyroid peroxidase (TPO) antibodies in pregnant women with isolated hypothyroxinemia to exclude autoimmune thyroid disease; a positive result reclassifies the condition as subclinical hypothyroidism, which warrants levothyroxine therapy. (American Family Physician) Evidence level: low (observational data). 5, 6
Serially monitor pregnant patients with isolated hypothyroxinemia for the emergence of TPO antibodies, because seroconversion changes the diagnosis to autoimmune thyroid disease and alters management to include treatment. (American Family Physician) Evidence level: low (expert opinion). 5

Do not mistake isolated hypothyroxinemia (normal TSH, low free T4) for subclinical hypothyroidism (elevated TSH, normal free T4); the latter requires levothyroxine treatment during pregnancy. (American Family Physician) Evidence level: low (expert opinion). 5

Increase levothyroxine by 25–30% (≈ 25 µg for a patient on 75 µg) as soon as pregnancy is confirmed, without waiting for TSH results. 7

Untreated or inadequately treated hypothyroidism increases the risk of preeclampsia, low birth weight, placental abruption, fetal death, and permanent neurodevelopmental deficits in the child. 7
Hypothyroidism during the first trimester is specifically linked to cognitive impairment in offspring. 7
Maintaining maternal euthyroidism—especially in the first and second trimesters when the fetus relies entirely on maternal thyroid hormone—is essential for normal fetal cognitive development. 7
Women who are adequately treated before conception or receive early treatment in pregnancy do not experience increased perinatal morbidity. 7

The recommended TSH target is < 2.5 mIU/L in the first trimester, then within trimester‑specific reference ranges for later trimesters. 7

Do not wait for TSH results before increasing levothyroxine in a pregnant woman with known hypothyroidism; fetal harm can occur before maternal symptoms appear. 7
Avoid TSH targets above 2.5 mIU/L in the first trimester, as even subclinical hypothyroidism is associated with adverse pregnancy outcomes. 7